Evaluation of Diagnostic Yield and Clinical Utility of Trio Whole‐Genome Sequencing in Children With GDD / IDD in China
Clinical Genetics · 03.11.2026
DOI: 10.1111/cge.70255 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Genetics, online erschienen am 03.11.2026. Verfasst von Jingwen Zhang und 14 weiteren Autor:innen. Beteiligte Einrichtung: Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangzhou, China. Die Arbeit nennt 25 Literaturangaben. Gefördert von: Key Projects of the National Key Research and Development Program, Scientific Research Project of the Bureau of Traditional Chinese Medicine of Guangdong Province, Medical Scientific Research Foundation of Guangdong Province of China.
Themen: Kinderkrankenpflege
Abstract (Originalsprache)
Accurate diagnosis and timely intervention are essential for improving outcomes in children with global developmental delay (GDD) or intellectual developmental disorder (IDD). Although genomic sequencing has improved diagnostic yield, studies integrating long‐term clinical follow‐up remain limited, hindering clinical translation. In this cohort study, 122 Chinese children with GDD/IDD were enrolled from a single center (2018–2023) and underwent Trio whole‐genome sequencing (Trio‐WGS). Trio‐WGS achieved a 39.3% (48/122) diagnostic yield, identifying pathogenic/likely pathogenic variants in 48 cases, including 35 SNVs/Indels and 13 CNVs. De novo variants accounted for 75% (36/48) of findings, with autosomal dominant inheritance predominant. Enrichment analysis revealed that, beyond the generic neurodevelopmental signature, the GDD/IDD diagnostic gene set was specifically enriched for presynaptic function, GABAergic/chloride transport, and chromatin remodeling. A multidisciplinary team used results to optimize care: 3 children improved with targeted therapy, 30 had comorbidity management adjusted, 17 received diet modifications, and 7 families pursued preimplantation genetic testing. This study holds great significance for improving the genetic diagnosis rate of GDD/IDD and identifying new mutations, while also providing valuable information for the treatment of GDD/IDD and reproductive guidance.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangzhou, China.
- Aegicare (Shenzhen) Technology Co. Ltd., Shenzhen, China.
ORCID-Profile: Xiaolin Lin, Xingyan He, Qiongxiang Zhai
Förderung
- Key Projects of the National Key Research and Development Program
- Scientific Research Project of the Bureau of Traditional Chinese Medicine of Guangdong Province
- Medical Scientific Research Foundation of Guangdong Province of China
- Guangdong Medical Research Foundation
Zitieren
APA
Zhang, J., Chen, Z., Zhang, Y., Liu, Y., Guo, Y., Zhang, H., Zeng, X., Lin, X., Meng, L., Zeng, T., Yu, W., Chen, C., He, X., Wang, C., & Zhai, Q. (2026). Evaluation of Diagnostic Yield and Clinical Utility of Trio Whole‐Genome Sequencing in Children With GDD / IDD in China. Clinical Genetics. https://doi.org/10.1111/cge.70255
Vancouver
Zhang J, Chen Z, Zhang Y, Liu Y, Guo Y, Zhang H, et al. Evaluation of Diagnostic Yield and Clinical Utility of Trio Whole‐Genome Sequencing in Children With GDD / IDD in China. Clinical Genetics. 2026. doi:10.1111/cge.70255
BibTeX
@article{Zhang2026,
author = {Zhang, Jingwen and Chen, Zhihong and Zhang, Yuxin and Liu, Yongchu and Guo, Yuxiong and Zhang, Huiqiong and Zeng, Xiaolu and Lin, Xiaolin and Meng, Liyun and Zeng, Tianqian and Yu, Weibin and Chen, Chunlin and He, Xingyan and Wang, Chun and Zhai, Qiongxiang},
title = {Evaluation of Diagnostic Yield and Clinical Utility of Trio Whole‐Genome Sequencing in Children With GDD / IDD in China},
journal = {Clinical Genetics},
year = {2026},
doi = {10.1111/cge.70255}
}
EUVIMED